Nanoligent
Explore how Nanoligent uses cutting-edge technology to design precision medicines, enhancing treatment efficacy and patient outcomes.
$14.01M ·
All 2 rounds ↓Signals
Website registeredMar 3, 2017 (9 years old)
Funding rounds
- Round · $14.01M
- Seed · amount undisclosedSource: fundraisingfox.com
- Website created
Founders and team
- MRManuel Rodríguez Co-Founder and Chairmansource: nanoligent.com
MC
Montserrat Cano Biosca Chief Executive Officer
Investors
AAVANTECA Partners
CCDTI Innovación's INNVIERTE program
CClave Capital
Ii&i Biotech Fund
IIAG Capital Partners
IInveready
IItalian Angels for Growth
Companies like Nanoligent
OOncoHost$35M Series B+ · May 2022
EEtcemblySeed · Apr 2026MMetabolic Psychiatry Labs
QQubit PharmaceuticalsSeed · Jun 2022
LLatus Bio$97M Series A · May 2026
DDebut$20M · Aug 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nanoligent (get a free API key).